Ossfinity | synthetic injectable putty

Ossfinity | synthetic injectable putty for bone void filling

Ossfinity is an injectable bone substitute for filling of bony or cartilage voids of the skeletal system. It is a synthetic bone graft composed of Hydroxyapatite (HA), Beta Tricalcium Phosphate (ß-TCP) and hydrogel. Ossfinity synthetic injectable putty can be used as bone void filler in both spine and orthopaedic surgery and is a proven an excellent alternative to human bone, especially when used in with bone marrow or proline-rich proteins (PRPs). Ossfinity combines OssGrogranules and an absorbable hydrogel to create a putty, which acts as a carrier for rapid vascularisation and mineralisation.

For  more information on Leader Biomedical’s Ossfinity synthetic bone substitute putty, simply fill in the below request form and receive the Ossfinity® Product Summary Sheet directly in your inbox. You can also contact us directly at info@leaderbiomedical.com

Please send this document to my inbox

Fields marked with * are required
Ossfinity synthetic injectable putty

About synthetic bone grafts and putty 

There are no safety concerns or natural constraints to the availability of synthetic bone grafts. Synthetic bone grafts have proven to be an excellent alternative to human bone, especially when used in conjunction with bone marrow or proline-rich proteins (PRPs) to add osteoinductive properties to the graft
Leader Biomedical’s OssGro® and Ossfinity® line of synthetic bone grafts are produced with MBCP™ Technology, a proprietary method for producing high quality synthetic bone grafts composed of 60% HA and 40% βTCP. Unlike other bulk production methodologies, this process relies on a sophisticated process of synthesis with several heating steps. The use of this technology ensures good mechanical strength with resorption rates resembling real bone.

Ossfinity® synthetic injectable putty combines OssGro® granules and an absorbable hydrogel to create a putty, which acts as a carrier for rapid vascularisation and mineralisation. Leader Biomedical provides a full range of different sizes and shapes OssGro synthetic bone grafts and Ossfinity synthetic injectable putty for use in orthopaedic, spine and dental surgery.

 

MBCP™ Technology Advantage

  • Good mechanical strength with resorption rates resembling real bone
  • Ideal alternative for human bone
  • Synthetic bone substitute
  • 60% HA and 40% βTCP
  • Macroporosity + Microporosity
  • Permeability
  • Safety

 

Ossfinity®  indications:

  • Spinal Fusion
  • Osteotomies
  • Maxillofacial applications
  • Bone tumour treatment
  • Vertebral fusion
  • Lumbar fusion
  • Arthroplasty surgeries
  • tlif
  • plif
  • xlif

 

About Leader Biomedical

Leader Biomedical is a medical devices company specialising in marketing and distributing targeted therapeutic solutions, medical equipment, and medical instruments for the operating room, to medical device distributors and sales agents.